PAX1 and cervical cancer: These data suggested the efficacy of PAX1 methylation as a biomarker for cervical cancer screening, and that it plays a guiding role in triage management of LSIL, HSIL, and SCC patients, as well as displays higher accuracy than single HPV‐DNA testing.